000 | 02004 a2200625 4500 | ||
---|---|---|---|
005 | 20250516012232.0 | ||
264 | 0 | _c20110222 | |
008 | 201102s 0 0 eng d | ||
022 | _a1938-0690 | ||
024 | 7 |
_a10.3816/CLC.2010.n.051 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aD'Jaen, Gabriela A | |
245 | 0 | 0 |
_aHuman immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. _h[electronic resource] |
260 |
_bClinical lung cancer _cNov 2010 |
||
300 |
_a396-404 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdenocarcinoma _xepidemiology |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAge of Onset |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xmethods |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xepidemiology |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aDatabases, Factual |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHIV Infections _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInternational Cooperation |
650 | 0 | 4 |
_aLung Neoplasms _xepidemiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aSEER Program _xstatistics & numerical data |
650 | 0 | 4 | _aSurvival |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aPantanowitz, Liron | |
700 | 1 | _aBower, Mark | |
700 | 1 | _aBuskin, Susan | |
700 | 1 | _aNeil, Nancy | |
700 | 1 | _aGreco, Erin M | |
700 | 1 | _aCooley, Timothy P | |
700 | 1 | _aHenry, David | |
700 | 1 | _aStem, Jonathan | |
700 | 1 | _aDezube, Bruce J | |
700 | 1 | _aStebbing, Justin | |
700 | 1 | _aAboulafia, David M | |
773 | 0 |
_tClinical lung cancer _gvol. 11 _gno. 6 _gp. 396-404 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3816/CLC.2010.n.051 _zAvailable from publisher's website |
999 |
_c20361035 _d20361035 |